Cargando…

Dual antibody-aided mesoporous nanoreactor for H(2)O(2) self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) represents a formidable challenge due to the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, rendering it unresponsive to conventional hormonal and targeted therapies. This study intro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ying-Tzu, Luo, Ying-Xiang, Chan, Shih-Hsuan, Chiu, Wen-Yi, Yang, Hung-Wei W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594761/ https://www.ncbi.nlm.nih.gov/pubmed/37875918 http://dx.doi.org/10.1186/s12951-023-02154-0

Ejemplares similares

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
por: Yang, Xiao-Xin, et al.
Publicado: (2022)

Fabrication of an Au-doped Cu/Fe oxide-polymer core–shell nanoreactor with chemodynamic and photodynamic dual effects as potential cancer therapeutic agents
por: Sun, Chun-Kai, et al.
Publicado: (2022)

Cu(2+)-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy
por: Zhang, Yanyan, et al.
Publicado: (2022)

Remodeling nanodroplets into hierarchical mesoporous silica nanoreactors with multiple chambers
por: Ma, Yuzhu, et al.
Publicado: (2022)

Multifunctional metal-organic framework-based nanoreactor for starvation/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy
por: Dai, Liangliang, et al.
Publicado: (2022)

Recent advanced development of metal-loaded mesoporous organosilicas as catalytic nanoreactors
por: Liang, Yucang
Publicado: (2021)

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
por: Leone, Robert D., et al.
Publicado: (2015)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Epigenetic checkpoint blockade: new booster for immunotherapy
por: Wang, Ziqiao, et al.
Publicado: (2021)

Construction of hollow mesoporous silica nanoreactors for enhanced photo-oxidations over Au-Pt catalysts
por: Tian, Hao, et al.
Publicado: (2020)

Self‐Supply of O(2) and H(2)O(2) by a Nanocatalytic Medicine to Enhance Combined Chemo/Chemodynamic Therapy
por: Gao, Shutao, et al.
Publicado: (2019)

Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO(2) as gatekeeper
por: Wang, Zhaoyang, et al.
Publicado: (2023)

Nanoreactors for green catalysis
por: De Martino, M Teresa, et al.
Publicado: (2018)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2021)

Controlled Synthesis of Manganese Oxide Nanoparticles Encaged in Hollow Mesoporous Silica Nanoreactors and Their Enhanced Dye Degradation Activity
por: Wei, Jinxia, et al.
Publicado: (2020)

CuS nanoparticles and camptothecin co-loaded thermosensitive injectable hydrogel with self-supplied H(2)O(2) for enhanced chemodynamic therapy
por: Tang, Wenxue, et al.
Publicado: (2022)

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
por: Lee, Ju Yeon, et al.
Publicado: (2016)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
por: Wilkinson, Robert W., et al.
Publicado: (2018)

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2018)

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020)

Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
por: Wang, Dongdong, et al.
Publicado: (2023)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Hollow Mesoporous CeO(2)-Based Nanoenzymes Fabrication for Effective Synergistic Eradication of Malignant Breast Cancer via Photothermal–Chemodynamic Therapy
por: Tan, Huaxin, et al.
Publicado: (2022)

H(2)O(2)/O(2) self-supply and Ca(2+) overloading MOF-based nanoplatform for cascade-amplified chemodynamic and photodynamic therapy
por: Liang, Yujia, et al.
Publicado: (2023)

Environmental chemodynamics : movement of chemicals in air, water, and soil /
por: Thibodeaux, Louis J.
Publicado: (1996)

TiSe(2)-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
por: Chen, Libin, et al.
Publicado: (2022)

Chemodynamic nanomaterials for cancer theranostics
por: Xin, Jingqi, et al.
Publicado: (2021)

Tip-induced nanoreactor for silicate
por: Gao, Ming, et al.
Publicado: (2015)

Hydrogenation of Toluene to Methyl Cyclohexane over PtRh Bimetallic Nanoparticle-Encaged Hollow Mesoporous Silica Catalytic Nanoreactors
por: Li, Kaijie, et al.
Publicado: (2021)

Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
por: Chuang, Yu-Chen, et al.
Publicado: (2020)

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens
por: Gubin, Matthew M., et al.
Publicado: (2014)

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
por: Guram, Kripa, et al.
Publicado: (2019)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
por: Duan, Jingjing, et al.
Publicado: (2018)

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
por: Duan, Xiaopin, et al.
Publicado: (2019)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
por: Lin, Xiaoning, et al.
Publicado: (2021)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
por: Davidson, Tara, et al.
Publicado: (2022)

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
por: Yang, Jing, et al.
Publicado: (2022)

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
por: Lee, Junghwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bj7ar1vj60do9obt5mq6gamk62